Nobilis Health Corp.
NHC.TO
TSX
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Net Income | 122.98% | -207.12% | 254.64% | -36.03% | 166.10% |
| Total Depreciation and Amortization | 10.22% | 32.54% | 26.91% | 0.04% | 15.99% |
| Total Amortization of Deferred Charges | -2.94% | -9.57% | 200.80% | 0.81% | 13.76% |
| Total Other Non-Cash Items | -60.63% | -90.65% | 3,481.58% | -112.86% | 712.77% |
| Change in Net Operating Assets | -2,555.09% | 99.03% | -543.38% | 196.88% | -137.32% |
| Cash from Operations | -97.64% | 278.50% | -115.58% | 305.72% | -85.71% |
| Capital Expenditure | -8.74% | 6.01% | 45.96% | -326.35% | 91.56% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -5,743.72% | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 29.89% | 98.86% | -2,387.46% | -635.47% | 97.40% |
| Total Debt Issued | -66.67% | -88.00% | -- | 100.00% | -120.49% |
| Total Debt Repaid | -9.39% | -96.96% | 5.22% | 48.73% | -344.21% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.07% | -0.26% | -355.11% | -211.88% | 80.79% |
| Cash from Financing | -371.85% | -103.05% | 1,867.34% | 37.81% | -376.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,054.20% | 106.06% | -336.12% | 353.17% | -129.44% |
